Commercialisation Partner Network
The Commercialisation Partner Network (CPN) builds the capability to turn science findings into commercially viable products.
Search Results
Displaying 181 - 190 results of 456 for:
annual report
Crown entities and statutory boards
We monitor Crown Research Institutes (CRIs), Crown entity companies, statutory entities and Public Finance Act 1989 Schedule 4A non-listed companies. This page provides information on these entities and the current members of boards.
Kupu whakataki a te kaihautū – Chief Executive’s foreword
Kei te tino harikoa au ki te whakatakoto atu i te pūrongo ā-tau a Hīkina Whakatutuki mō te tau 2018/19. It gives me great pleasure to present the Ministry of Business, Innovation and Employment’s (MBIE) 2018/19 Annual Report.
Ribonucleic Acid (RNA) Development platform
The Government is investing in a Strategic Science Investment Fund (SSIF) platform for Ribonucleic Acid (RNA) development. This is to ensure New Zealand has well-connected and world-class research capability to strengthen the use and commercialisation of RNA technology.
PreSeed Accelerator Fund
Funding commercialisation projects from publicly funded research.
Adjustments to the Climate-related Disclosures Regime - summary of discussion document
The Ministry of Business, Innovation, and Employment is seeking public feedback on potential adjustments to the climate-related disclosures regime. We encourage feedback from climate reporting entities, the wider financial markets industry and the public.
Holidays Act reform: Employment Leave Bill
Passing new employment leave legislation is a priority for the Government.
Financial performance
Infectious Disease research platform
The Government is investing in an Infectious Disease research platform to ensure New Zealand has world class research capability to respond to serious infectious disease threats.